A study of the clinical, treatment planning and dosimetric feasibility of dose painting in external beam radiotherapy of prostate cancer
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 15, 66-71
Abstract
No abstract availableKeywords
Funding Information
- University Hospitals Bristol NHS Foundation Trust
This publication has 30 references indexed in Scilit:
- Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic RatioClinical Oncology, 2016
- Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe Lancet Oncology, 2015
- Technical Note: MRI only prostate radiotherapy planning using the statistical decomposition algorithmMedical Physics, 2015
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trialThe Lancet Oncology, 2012
- Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trialTrials, 2011
- Molecular Imaging–Based Dose Painting: A Novel Paradigm for Radiation Therapy PrescriptionSeminars in Radiation Oncology, 2011
- 28 Quality Assurance of Dosimetry in Centres participating in the CHHIP Prostate Radiotherapy TrialClinical Oncology, 2007
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- A technique for the quantitative evaluation of dose distributionsMedical Physics, 1998